Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban: The Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation

Study Questions:

What are the clinical characteristics of patients treated with rivaroxaban for stroke prevention in atrial fibrillation (AF), who experienced intracranial hemorrhage (ICH) events?